17 Jun 2021

Lyell Immunopharma

NewsHeat chart

  • Week
  • Month
  • Year
  • Media news
  • Corp news
Click to unlock the chart

The data in the chart above is based on data derived from our proprietary XP calculation model and may be changed, adjusted and updated without prior notice

Company Valuation

  • Valuation
  • Share Price
  • Cumulative Funding

The data in the tables and charts is based on data from public sources and although we make every effort to compile the data, it may not coincide with the actual data of the issuer.

Funding Round
Funding Amount
Post-Money Valuation
Share Price

News related to Lyell Immunopharma4

Filter by
Sort by
Lyell Immunopharma
Jun 11, 2021Show on chart

S-1

common stock and each two-year anniversary of the IPO thereafter, the closing of a change in control  ...

https://www.sec.gov/Archives/edgar/data/1806952/000119312521172500/d168165ds1.htm
Lyell Immunopharma
Jun 11, 2021Show on chart

LYEL | Lyell Immunopharma - Pre-IPO | MarketWatch

Company. Lyell Immunopharma. Address. N/A. City/State. South San Francisco, CA. Phone. N/A. Industry. Health-Biotech. Employees. 190....

https://www.marketwatch.com/investing/stock/lyel/ipo
Lyell Immunopharma
Jun 11, 2021Show on chart

Lyell Immunopharma Seeks $425 Million IPO (Pending:LYEL ...

Quick Take. Lyell Immunopharma (LYEL) has filed to raise $425 million in an IPO of its common stock, according to an S-1/A registration ...

https://seekingalpha.com/article/4433934-lyell-immunopharma-seeks-425-million-ipo
Lyell Immunopharma
Jun 11, 2021Show on chart

Lyell Immunopharma to be valued at up to $4.4 billion after IPO ...

LYEL, has set terms of its initial public offering, which would value the California- based T cell reprogramming company at up to $4.37 billion. The ...

https://www.marketwatch.com/story/lyell-immunopharma-to-be-valued-at-up-to-44-billion-after-ipo-terms-set-2021-06-09